Biomarker-Concordant Steroid Administration in Severe Coronavirus Disease-2019
Aysun Tekin(Mayo Clinic), Philippe Clevenbergh, Rolando Claure‐Del Granado(Universidad Mayor de San Simón), Vishakha K. Kumar(Society of Critical Care Medicine), Diana J. Valencia Morales(Mayo Clinic in Arizona), Jean-Baptiste Mesland(Cliniques Universitaires Saint-Luc), Juan Pablo Domecq(Mayo Clinic Health System), Oscar Y. Gavidia, Rahul Kashyap(WellSpan Health), Yewande Odeyemi(Mayo Clinic), Rodrigo Cartin‐Ceba, Ognjen Gajic(Mayo Clinic), И. Б. Заболотских(Kuban State Medical University), Allan J. Walkey(Boston University), Krishna Mohan Surapeneni(Panimalar Medical College Hospital & Research Institute)
Cited by 4
Related Papers
Patient engagement in research: a systematic review
|BMC Health Services Research|2014|1.8k
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy
|JAMA|2019|370
Drugs Commonly Associated With Weight Change: A Systematic Review and Meta-analysis
|The Journal of Clinical Endocrinology & Metabolism|2015|328
Impact of Infectious Diseases Specialists and Microbiological Data on the Appropriateness of Antimicrobial Therapy for Bacteremia
|Clinical Infectious Diseases|1999|266